Deals
Pfizer Approached Allergan About Merger: WSJ
- A deal would be among the biggest ever in the pharma industry
- Discussions are at early stage and obstacles remain, WSJ says
Possible Allergan Deal Could See Pfizer Split Up
This article is for subscribers only.
Pfizer Inc. and Allergan Plc are considering a merger, the Wall Street Journal reported, setting the stage for a deal that could be among the largest in the drug industry’s history and give Pfizer control of the Botox cosmetic drug.
Pfizer recently approached Allergan and the process is at an early stage, the Journal said, citing people familiar with the matter. Though details of the talks are unclear, they could face obstacles such as agreeing on price, layoffs and closing of facilities, the Journal said.